Daas A - Search Results

1

Feasibility study to evaluate the correlation between results of a candidate in vitro assay and established in vivo assays for potency determination of Newcastle disease vaccines.

Claassen I, Maas R, Daas A, Milne C. Claassen I, et al. Among authors: daas a. Pharmeuropa Bio. 2003 Jul;2003(1):51-66. Pharmeuropa Bio. 2003. PMID: 14563308

2

Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.

Lensing HH, Behr-Gross ME, Daas A, Spieser JM. Lensing HH, et al. Among authors: daas a. Dev Biol (Basel). 2002;111:69-76. Dev Biol (Basel). 2002. PMID: 12678226

3

Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay.

Fuchs F, Minor P, Daas A, Milne C. Fuchs F, et al. Among authors: daas a. Pharmeuropa Bio. 2003 Jul;2003(1):23-50. Pharmeuropa Bio. 2003. PMID: 14563307

4

Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.

Winsnes R, Sesardic D, Daas A, Behr-Gross ME. Winsnes R, et al. Among authors: daas a. Pharmeuropa Bio. 2004 Jan;2003(2):35-68. Pharmeuropa Bio. 2004. PMID: 14960262

5

Establishment of European Pharmacopoeia (Ph. Eur.) Biological Reference Preparations (BRP) batch 2 for rDNA hepatitis B vaccine (method A and B).

Dobbelaer R, Daas A, Milne C. Dobbelaer R, et al. Among authors: daas a. Pharmeuropa Bio. 2004 Jan;2003(2):77-90. Pharmeuropa Bio. 2004. PMID: 14960264

6

Validation study to evaluate the reproducibility of a candidate in vitro potency assay of newcastle disease vaccines and to establish the suitability of a candidate biological reference preparation.

Claassen I, Maas R, Oei H, Daas A, Milne C. Claassen I, et al. Among authors: daas a. Pharmeuropa Bio. 2004 Dec;2004(1):1-15. Pharmeuropa Bio. 2004. PMID: 15659281

7

Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use.

Daas A, Milne C. Daas A, et al. Pharmeuropa Bio. 2004 Dec;2004(1):17-22. Pharmeuropa Bio. 2004. PMID: 15659282

8

Feasibility study to develop a common in vitro D antigen assay for inactivated poliomyelitis vaccines.

Morgeaux S, Milne C, Daas A. Morgeaux S, et al. Among authors: daas a. Pharmeuropa Bio. 2005 Sep;2005(1):19-26. Pharmeuropa Bio. 2005. PMID: 16336935

9

Establishment of European pharmacopoeia Mycoplasma reference strains.

Milne C, Daas A. Milne C, et al. Among authors: daas a. Pharmeuropa Bio. 2006 Nov;2006(1):57-72. Pharmeuropa Bio. 2006. PMID: 17270132

10

Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccine (part 2).

Winsnes R, Sesardic D, Daas A, Behr-Gross ME. Winsnes R, et al. Among authors: daas a. Pharmeuropa Bio. 2006 Nov;2006(1):73-88. Pharmeuropa Bio. 2006. PMID: 17270133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters